Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression
- PMID: 1905306
- DOI: 10.1007/BF00917745
Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression
Abstract
We previously reported that increased production of prostaglandin E2 by monocytes is a pivotal mechanism in posttrauma immunopathology. Here we characterize monocyte levels of transforming growth factor beta and examine the effects of elevated transforming growth factor beta on prostaglandin E2 release by patients' monocytes. Trauma patients' and normals' monocyte supernates (+/- stimulation with muramyl dipeptide) were acid treated and assayed for transforming growth factor beta using the mink lung-cell bioassay. Alternatively, human transforming growth factor beta was added to patients' and normals' monocytes and prostaglandin E2 production assayed. Significantly elevated transforming growth factor beta levels (median = 181.7 pmol/10(6) monocytes) were detected in immunosuppressed patients' monocytes but not immunocompetent trauma patients' (median = 32.0 pM) or normals' (median = 20.4 pM) monocytes. Adding transforming growth factor beta to monocytes resulted in a significant elevation of prostaglandin E2 levels. Elevated monocyte transforming growth factor beta levels in trauma patients could be both suppressing T-lymphocyte functions and maintaining elevated monocyte prostaglandin E2 synthesis.
Similar articles
-
Elevated monocyte interleukin-6 (IL-6) production in immunosuppressed trauma patients. I. Role of Fc gamma RI cross-linking stimulation.J Clin Immunol. 1991 Nov;11(6):326-35. doi: 10.1007/BF00918798. J Clin Immunol. 1991. PMID: 1837029
-
Elevated monocyte interleukin-6 (IL-6) production in immunosppressed trauma patients. II. Downregulation by IL-4.J Clin Immunol. 1991 Nov;11(6):336-44. doi: 10.1007/BF00918799. J Clin Immunol. 1991. PMID: 1761639
-
Elevated tumor necrosis factor alpha production concomitant to elevated prostaglandin E2 production by trauma patients' monocytes.Arch Surg. 1990 Jan;125(1):29-35. doi: 10.1001/archsurg.1990.01410130031004. Arch Surg. 1990. PMID: 2104744
-
Surgical trauma: hyperinflammation versus immunosuppression?Langenbecks Arch Surg. 2004 Nov;389(6):475-84. doi: 10.1007/s00423-004-0472-0. Epub 2004 May 28. Langenbecks Arch Surg. 2004. PMID: 15173946 Review.
-
The role of transforming growth factor-beta in inflammatory processes.Immunol Res. 1991;10(3-4):249-54. doi: 10.1007/BF02919701. Immunol Res. 1991. PMID: 1955749 Review. No abstract available.
Cited by
-
The release of transforming growth factor-beta following haemorrhage: its role as a mediator of host immunosuppression.Immunology. 1993 Jul;79(3):479-84. Immunology. 1993. PMID: 8406575 Free PMC article.
-
Effects of interleukin-6 (IL-6) and transforming growth factor-beta (TGF-beta) on neutrophil elastase release.Inflammation. 1995 Feb;19(1):83-99. doi: 10.1007/BF01534383. Inflammation. 1995. PMID: 7705889
-
PATHOLOGICAL ASPECTS OF THE ANTI-INFLAMMATORY/IMMUNE SUPPRESSIVE RESPONSE IN SEPSIS AND SHOCK.Rec Res Dev Immunol. 2003 Jan 12;5:13-35. Rec Res Dev Immunol. 2003. PMID: 23181245 Free PMC article.
-
Immune response of severely injured patients--influence of surgical intervention and therapeutic impact.Langenbecks Arch Surg. 2007 Sep;392(5):639-48. doi: 10.1007/s00423-007-0203-4. Epub 2007 Jun 29. Langenbecks Arch Surg. 2007. PMID: 17605036 Review.
-
Therapeutic potential of HMGB1-targeting agents in sepsis.Expert Rev Mol Med. 2008 Nov 4;10:e32. doi: 10.1017/S1462399408000884. Expert Rev Mol Med. 2008. PMID: 18980707 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical